arsenic has been researched along with fluorodeoxyglucose f18 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, H; Ito, I; Kubota, K; Nagahama, F; Okamoto, T; Sonehara, Y; Tateishi, U; Tsuchiya, J | 1 |
1 trial(s) available for arsenic and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multice
Topics: Aged; Arsenicals; Asia; Biomarkers; Female; Fluorodeoxyglucose F18; Glutathione; Humans; Internationality; Japan; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; North America; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radiology; Radiopharmaceuticals; Reference Standards; Societies, Medical; Treatment Outcome | 2018 |